Breaking News

  • 8 hours ago

  • Vaibhavi M.

Acurx Expands Global Patent Portfolio With Korea Grant For Novel Antibiotic Platform, Strengthens DNA Polymerase IIIC Inhibitor Program For Resistant Infections
Breaking News

More News

FDA Approves Biogen’s High-Dose SPINRAZA To Enhance Treatment Outcomes In Spinal Muscular Atrophy

FDA Approves Biogen’s High-Dose SPINRAZA To Enhance Treatment Outcomes...

Vaibhavi M.

BridgeBio Files FDA NDA For BBP-418, Targets Breakthrough In Muscular Dystrophy Treatment

BridgeBio Files FDA NDA For BBP-418, Targets Breakthrough In Muscular ...

Vaibhavi M.

Baxter Showcases IV Verify System To Improve Medication Safety And Nursing Efficiency At Bedside

Baxter Showcases IV Verify System To Improve Medication Safety And Nur...

Vaibhavi M.

GSK’s Depemokimab Gains NMPA Approval, Delivering Significant Reduction In Asthma Exacerbations

GSK’s Depemokimab Gains NMPA Approval, Delivering Significant Reductio...

Simantini Singh Deo

Ad
Advertisement
Magazine Cover
Jan-Feb 2026 Edition Issue

Beyond CSR- ESG Moves Into Boardrooms

  • Cover Story: ESG in Pharma.
  • In Talks with Leadership: Featuring Mr. Abhay Kumar Srivastava
  • Market Insights: Packaging transformation &  AI-led drug repurposing.
  • Startup & Innovation: How GenepoweRx is transforming the genomic landscape.
  • Manufacturing: Biocatalysis, automation, digital labs, and smart pharma operations.
Ad
Advertisement
Ad